It’s not impossible to get infected with SARS-CoV-2 from contaminated surfaces—but the risk is extremely low—less than 1 in 10,000, the CDC confirmed yesterday,

Overlooked during the global fixation on vaccinations: oral antivirals pills.   A pill-based “Tamiflu approach” would be easier than current therapies like monoclonal antibodies and convalescent plasma that need intravenous infusions.

Good news on reinfection front: US NIH researchers found that people with SARS-CoV-2 antibodies showed “substantial” immunity to the virus at least for a few months, 

A new South Africa variant of SARS-CoV-2 is prompting concerns about increased transmission and how effective current vaccines will be against it,

The SARS-CoV-2 mutation now rapidly spreading across England’s South East is potentially up to 70% more infectious than its predecessor—but not necessarily more dangerous, according to a new 

Could a novel strain of SARS-CoV-2 identified this month be linked to an accelerating spread in the country’s southeast? 

WHO advisors are meeting today to discuss deliberately infecting young, healthy volunteers with SARS-CoV-2 to hasten vaccine development—despite the promising vaccines already on the way.   Pros: Faster results than conventional vaccine field trials…

117 pages of leaked documents reveal that early in the pandemic, China offered the world a partial picture of what they knew and a more optimistic forecast than what was evidenced on the ground.   Despite the virus’s novelty, there was “evidence of clear missteps” and “a…

Less disruptive and costly COVID-19 restrictions can work as well as more intrusive steps like lockdowns to slow the spread of SARS-CoV2, according to a new study ranking the effectiveness of government interventions around the world. The researchers from the Medical…

More good vaccine news broke this morning as biotech company Moderna announced